Product Information

TREMFYA 100 MG/ML ONE-PRESS is a brand product labeled by Janssen Biotech, Inc., priced at $14745.8421 per ML under NDC 57894064011. Its NADAC has been published 196 times since Nov 23, 2022.

TREMFYA 100 MG/ML ONE-PRESS

Guselkumab
$14745.8421per ML

Strength

100 mg/mL

NDC

57894064011

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

GUSELKUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA761061

On Market Since

7/13/2017

Pharmacological Classes

Interleukin-23 Antagonist
Interleukin-23 Antagonists

Price Statistics

The NADAC for TREMFYA 100 MG/ML ONE-PRESS has been published 196 times since Nov 23, 2022, and over the history we have for it it has risen 20.5%. The table below summarizes its recorded NADAC range and movement.

Current price$14745.8421 per ML
All-time high$14766.3280 (Jun 10, 2026)
All-time low$12239.5220 (Nov 23, 2022)
52-week high$14766.3280
52-week low$14019.5917
Median price$13494.0730
Average price$13564.5077
Largest weekly change+5.0% (Jan 31, 2024)
Weeks tracked196
Tracking sinceNov 23, 2022

Price History

1W

+0.2%

1M

+0.2%

3M

-0.1%

6M

-0.1%

1Y

+5.2%

3Y

+14.7%

5Y

N/A

All

+20.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of TREMFYA 100 MG/ML ONE-PRESS?

The current National Average Drug Acquisition Cost (NADAC) for TREMFYA 100 MG/ML ONE-PRESS, manufactured by Janssen Biotech, Inc., is $14745.8421 per ML (NDC 57894064011), effective Aug 19, 2026.

How has the price of TREMFYA 100 MG/ML ONE-PRESS changed over time?

Over the history we have for it, the NADAC for TREMFYA 100 MG/ML ONE-PRESS has risen 20.5%. It has been tracked across 196 weekly CMS publications since Nov 23, 2022.

What are the highest and lowest recorded NADAC prices for TREMFYA 100 MG/ML ONE-PRESS?

Since Nov 23, 2022, the NADAC for TREMFYA 100 MG/ML ONE-PRESS has ranged from a low of $12239.5220 (Nov 23, 2022) to a high of $14766.3280 (Jun 10, 2026), with a median of $13494.0730 per ML.

Are there cheaper alternatives to TREMFYA 100 MG/ML ONE-PRESS?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TREMFYA 100 MG/ML SYRINGE, is $14728.9053 per ML — about 0% below TREMFYA 100 MG/ML ONE-PRESS.

Who manufactures TREMFYA 100 MG/ML ONE-PRESS?

TREMFYA 100 MG/ML ONE-PRESS (NDC 57894064011) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.